Glucose Meters | AgaMatrix
Update and Advances in Technology For Diabetes Self Management PDF | PDF | Diabetes Mellitus | Mobile App
Hacking Diabetes - #wearenotwaiting
Reorganization, and Formation of WaveForm Technologies Inc.
Glucose Meters | AgaMatrix
AgaMatrix & WaveForm Complete $56 Million Capital Raise
Reorganization, and Formation of WaveForm Technologies Inc.
AgaMatrix | Innovative Products for Diabetes Care
WaveForm Technologies Inc Awarded CE Mark Approval
WaveForm Gets Favorable Decision on Glucose Monitoring Patents
WaveForm Technologies Inc. Awarded CE Mark Approval for Their Continuous Glucose Monitoring System
Diabetes Technology Society
PCSK9 inhibition in children with familial hypercholesterolaemia
Company | Waveform
Oregon medical device maker raises $56M - Portland Business Journal
Assessment of a Decision Support System for Adults with Type 1 Diabetes on Multiple Daily Insulin Injections | Diabetes Technology & Therapeutics
Federal Judge Awards AgaMatrix While Admonishing Dexcom
About | Waveform
Agamatrix - 8000-01971 - Lancet For Lancing Device Wavesense? 33 Gauge Non-Safety Twist Off Cap Finger | StomaBags.com
Empagliflozin add-on therapy to closed-loop insulin delivery in type 1 diabetes: a 2 × 2 factorial randomized crossover trial | Nature Medicine
With $32M loan, connected glucometer pioneer AgaMatrix will split company into CGM, BGM businesses | MobiHealthNews
Comparison Between Closed-Loop Insulin Delivery System (the Artificial Pancreas) and Sensor-Augmented Pump Therapy: A Randomized-Controlled Crossover Trial | Diabetes Technology & Therapeutics
Opportunities and challenges in closed-loop systems in type 1 diabetes - The Lancet Diabetes & Endocrinology
Reorganization, and Formation of WaveForm Technologies Inc.
Improving HbA1c levels with advanced hybrid closed-loop therapy - The Lancet Diabetes & Endocrinology
Biosensor market to double to $40 billion by 2026 | Fierce Electronics
Bayer, WaveForm in tie-up for glucose monitoring solutions for China - Chinadaily.com.cn
